Comparative Effectiveness of Integrative Care and Conventional Care in Cardiovascular Disease Risk Reduction Among Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Systematic Review of Real-World Data

Authors

  • Asfandiyar Khan Department of Cardiology, Lady Reading Hospital, Peshawar, KP, Pakistan.
  • Biruktawit Petros Department of Medicine, Irhythm Technologies, Houston, Texas, USA.
  • Shahbaz Ali Department of Emergency Medicine, Our Lady of Lourdes Hospital, Drogheda, Ireland
  • Roohana Mustafa Department of Internal Medicine, Abbasi Shaheed Hospital, Karachi, Pakistan.
  • Erum Khan Community medicine, Karachi Medical and Dental College, Karachi Metropolitan University, Pakistan
  • Aeliya Batool Department of Pharmacology Karachi Metropolitan University, Karachi Medical and Dental College, Sindh, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v2i02.176

Keywords:

Integrative Care, Conventional Care, Cardiovascular Disease, Type 2 Diabetes Mellitus, Systematic Review, Real-World Data

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) significantly increases the risk of cardiovascular disease (CVD). Integrative care (IC) offers a personalized and multifaceted approach to managing T2DM, but its effectiveness compared to conventional care (CC) in reducing CVD risk remains underexplored.

Objective: This systematic review aims to assess the comparative effectiveness of IC versus CC in reducing CVD risk among newly diagnosed T2DM patients, utilizing real-world data.

Methods: We conducted a systematic review of studies published from 2014 to 2024 that compared IC and CC in newly diagnosed T2DM patients. Real-world data sources were analyzed, including electronic health records, cohort studies, and registries. Data were extracted on CVD outcomes, glycemic control, lipid profiles, and quality of life. The effectiveness of IC and CC was evaluated using meta-analysis and comparative statistical techniques.

Results: The review included 5 studies with a total of 5,450 participants. Integrative care (IC) was associated with a significantly lower risk of major cardiovascular events compared to conventional care (CC), with a hazard ratio (HR) of 0.68 (95% CI: 0.55-0.84). Patients receiving IC demonstrated improvements in glycemic control, lipid profiles, and blood pressure, along with higher quality of life scores. The benefits of IC were especially evident in high-risk populations and among those with extended follow-up periods.

Conclusions: Integrative care demonstrates superior effectiveness in reducing CVD risk among newly diagnosed T2DM patients compared to conventional care. The holistic and personalized nature of IC contributes to improved cardiovascular outcomes and overall patient well-being. These findings support the adoption of integrative approaches in diabetes management to enhance long-term health outcomes.

References

Ma, C.-X., et al., Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovascular diabetology, 2022. 21(1): p. 74.

Salaxiddinovich, S.S., et al., Heart Rhythm in Patients with Type 2 Diabetes Mellitus Depending on the Degree of Glycemia. Journal of Science in Medicine and Life, 2024. 2(5): p. 7-11.

Umer, A., et al., Evaluating the Iron Deficiency Anemia in Type-II Diabetic Patients Taking Metformin and its Association with Oxidative Stress. Indus Journal of Bioscience Research, 2024. 2(02): p. 178-182.

Hossain, M.J., M. Al‐Mamun, and M.R. Islam, Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Science Reports, 2024. 7(3): p. e2004.

Kovács, H., Impact of Glucose Metabolism on Cardiovascular Health: From Hyperglycemia to Diabetes. Innovative Life Sciences Journal, 2024. 4(1): p. 1− 10-1− 10.

Wong, N.D. and N. Sattar, Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nature Reviews Cardiology, 2023. 20(10): p. 685-695.

Lorber, D., Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes, metabolic syndrome and obesity: targets and therapy, 2014: p. 169-183.

Das, S.R., et al., 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. Journal of the American College of Cardiology, 2018. 72(24): p. 3200-3223.

Zonneveld, N., et al., Values of integrated care: a systematic review. International journal of integrated care, 2018. 18(4).

Wan, T.T., Population Health Management for Poly Chronic Conditions. Cham: Springer, 2018.

Bicego, A., et al., Complementary treatment comparison for chronic pain management: A randomized longitudinal study. PLoS One, 2021. 16(8): p. e0256001.

Murtagh, S., et al., Integrating primary and secondary care to enhance chronic disease management: a scoping review. International journal of integrated care, 2021. 21(1).

Flanagan, S., S. Damery, and G. Combes, The effectiveness of integrated care interventions in improving patient quality of life (QoL) for patients with chronic conditions. An overview of the systematic review evidence. Health and quality of life outcomes, 2017. 15: p. 1-11.

Martínez-González, N.A., et al., Integrated care programmes for adults with chronic conditions: a meta-review. International Journal for Quality in Health Care, 2014. 26(5): p. 561-570.

Alhazme, W.A., et al., NURSE-LED MANAGEMENT OF CHRONIC DISEASE. Neuropsychopharmacologia Hungarica, 2024. 22(2): p. 39-43.

Bibi, A., et al., Prevalence of Cardiovascular Diseases in District Buner Pakistan. Indus Journal of Bioscience Research, 2024. 2(02): p. 127-134.

Metzner, G., et al., Local, collaborative, stepped, and personalized care management for older people with chronic diseases–results from the randomized controlled LoChro-trial. BMC geriatrics, 2023. 23(1): p. 92.

Inzucchi, S.E., et al., Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care, 2015. 38(1): p. 140-149.

Banach, M., et al., Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022). Cardiovascular Diabetology, 2022. 21(1): p. 263.

Zeb, S., et al., AI in Healthcare: Revolutionizing Diagnosis and Therapy. International Journal of Multidisciplinary Sciences and Arts, 2024. 3(3): p. 118-128.

Ndumele, C.E., et al., Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation, 2023. 148(20): p. 1606-1635.

Downloads

Published

2024-11-13

How to Cite

Khan, A., Petros , B., Ali, S., Mustafa, R., Khan, E., & Batool, A. (2024). Comparative Effectiveness of Integrative Care and Conventional Care in Cardiovascular Disease Risk Reduction Among Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Systematic Review of Real-World Data. Indus Journal of Bioscience Research, 2(02), 345–354. https://doi.org/10.70749/ijbr.v2i02.176